Literature DB >> 22565291

Risk factors for neonatal sepsis and perinatal death among infants enrolled in the prevention of perinatal sepsis trial, Soweto, South Africa.

Stephanie J Schrag1, Clare L Cutland, Elizabeth R Zell, Locadiah Kuwanda, Eckhart J Buchmann, Sithembiso C Velaphi, Michelle J Groome, Shabir A Madhi.   

Abstract

BACKGROUND: Factors associated with neonatal sepsis, an important cause of child mortality, are poorly described in Africa. We characterized factors associated with early-onset (days 0-2 of life) and late-onset (days 3-28) -sepsis and perinatal death among infants enrolled in the Prevention of Perinatal Sepsis Trial (NCT00136370 at ClinicalTrials.gov), Soweto, South Africa.
METHODS: Secondary analysis of 8011 enrolled mothers and their neonates. Prenatal and labor records were abstracted and neonatal wards were monitored for hospitalized Prevention of Perinatal Sepsis-enrolled neonates. Endpoint definitions required clinical and laboratory signs. All univariate factors associated with endpoints at P < 0.15 were evaluated using multivariable logistic regression.
RESULTS: About 10.5% (837/8011) of women received intrapartum antibiotic prophylaxis; 3.8% of enrolled versus 15% of hospital births were preterm. Among 8129 infants, 289 had early-onset sepsis, 34 had late-onset sepsis, 49 had culture-confirmed neonatal sepsis and 71 died in the perinatal period. Factors associated with early-onset sepsis included preterm delivery [adjusted relative risk (aRR) = 2.6; 95% confidence interval (CI): 1.4-4.8]; low birth weight (<1500 g: aRR = 6.5, 95% CI: 2.4-17.3); meconium-stained amniotic fluid (MSAF) (aRR = 2.8, 95% CI: 2.2-3.7) and first birth (aRR = 1.8; 95% CI: 1.4-2.3). Preterm, low birth weight, MSAF and first birth were similarly associated with perinatal death and culture-confirmed sepsis. MSAF (aRR = 2.4, 95% CI: 1.1-5.0) was associated with late-onset sepsis.
CONCLUSIONS: Preterm and low birth weight were important sepsis risk factors. MSAF and first birth were also associated with sepsis and death, warranting further exploration. Intrapartum antibiotic prophylaxis did not protect against all-cause sepsis or death, underscoring the need for alternate prevention strategies.

Entities:  

Mesh:

Year:  2012        PMID: 22565291     DOI: 10.1097/INF.0b013e31825c4b5a

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  20 in total

1.  Bacteria and endotoxin in meconium-stained amniotic fluid at term: could intra-amniotic infection cause meconium passage?

Authors:  Roberto Romero; Bo Hyun Yoon; Piya Chaemsaithong; Josef Cortez; Chan-Wook Park; Rogelio Gonzalez; Ernesto Behnke; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo
Journal:  J Matern Fetal Neonatal Med       Date:  2013-12-16

2.  Contemporary Trends in Global Mortality of Sepsis Among Young Infants Less Than 90 Days: A Systematic Review and Meta-Analysis.

Authors:  Ming Ying Gan; Wen Li Lee; Bei Jun Yap; Shu Ting Tammie Seethor; Rachel G Greenberg; Jen Heng Pek; Bobby Tan; Christoph Paul Vincent Hornik; Jan Hau Lee; Shu-Ling Chong
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

3.  Culture-confirmed neonatal bloodstream infections and meningitis in South Africa, 2014-19: a cross-sectional study.

Authors:  Rudzani C Mashau; Susan T Meiring; Angela Dramowski; Rindidzani E Magobo; Vanessa C Quan; Olga Perovic; Anne von Gottberg; Cheryl Cohen; Sithembiso Velaphi; Erika van Schalkwyk; Nelesh P Govender
Journal:  Lancet Glob Health       Date:  2022-08       Impact factor: 38.927

4.  Secreted phospholipase A2 is increased in meconium-stained amniotic fluid of term gestations: potential implications for the genesis of meconium aspiration syndrome.

Authors:  Roberto Romero; Bo Hyun Yoon; Piya Chaemsaithong; Josef Cortez; Chan-Wook Park; Rogelio Gonzalez; Ernesto Behnke; Sonia S Hassan; Francesca Gotsch; Lami Yeo; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2014-01-06

5.  Risk factors for mortality among human immunodeficiency virus-exposed and unexposed infants admitted to a neonatal intensive care unit in Botswana.

Authors:  Rebecca M Zash; Olubunmi Ajose-Popoola; Ketil Stordal; Sajini Souda; Anthony Ogwu; Scott Dryden-Peterson; Kathleen Powis; Shahin Lockman; Joe Makhema; Max Essex; Roger L Shapiro
Journal:  J Paediatr Child Health       Date:  2013-12-23       Impact factor: 1.954

Review 6.  Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.

Authors:  Miwako Kobayashi; Johan Vekemans; Carol J Baker; Adam J Ratner; Kirsty Le Doare; Stephanie J Schrag
Journal:  F1000Res       Date:  2016-09-22

7.  Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1).

Authors:  Clare L Cutland; Stephanie J Schrag; Michael C Thigpen; Sithembiso C Velaphi; Jeannette Wadula; Peter V Adrian; Locadiah Kuwanda; Michelle J Groome; Eckhart Buchmann; Shabir A Madhi
Journal:  Emerg Infect Dis       Date:  2015-04       Impact factor: 6.883

8.  Risk Factors for Neonatal Sepsis in Public Hospitals of Mekelle City, North Ethiopia, 2015: Unmatched Case Control Study.

Authors:  Destaalem Gebremedhin; Haftu Berhe; Kahsu Gebrekirstos
Journal:  PLoS One       Date:  2016-05-10       Impact factor: 3.240

9.  Prevention of bacterial infections in the newborn by pre-delivery administration of azithromycin: Study protocol of a randomized efficacy trial.

Authors:  Anna Roca; Claire Oluwalana; Bully Camara; Abdoulie Bojang; Sarah Burr; Timothy M E Davis; Robin Bailey; Beate Kampmann; Jenny Mueller; Christian Bottomley; Umberto D'Alessandro
Journal:  BMC Pregnancy Childbirth       Date:  2015-11-19       Impact factor: 3.007

10.  Enterococcus faecium and Enterococcus faecalis in blood of newborns with suspected nosocomial infection.

Authors:  Isabela Furtado; Paula Cristhina Niz Xavier; Luciana Venhofen Martinelli Tavares; Fabiana Alves; Sarah Fonseca Martins; Almir de Sousa Martins; Durval Batista Palhares
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jan-Feb       Impact factor: 1.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.